» Articles » PMID: 33927679

COVID-19 Dysautonomia

Overview
Journal Front Neurol
Specialty Neurology
Date 2021 Apr 30
PMID 33927679
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

To report a case series of dysautonomia associated with COVID-19 infection. This is a retrospective review of patients evaluated in the autonomic clinic at our institution with suspected signs and symptoms of dysautonomia who underwent formal evaluation, including autonomic testing. Six patients were identified with signs and symptoms suggestive of dysautonomia who underwent autonomic testing. All patients had symptoms typical of COVID-19 infection, though none were hospitalized for these or other symptoms. All patients reported symptoms of postural lightheadedness and near-syncope, fatigue, and activity intolerance. Five patients reported the onset of autonomic symptoms concomitant with other COVID-19 symptoms, with the other patient reporting symptom onset 6 weeks following initial COVID-19 symptoms. Autonomic testing demonstrated an excessive postural tachycardia in 4 patients, a hypertensive response with head-up tilt in 3 patients, orthostatic hypotension in 1 patient, and sudomotor impairment in 1 of the patients with excessive postural tachycardia. We present clinical features and results of autonomic testing in 6 patients with a history COVID-19 infection. While all patients reported typical features of orthostatic intolerance, fatigue, and activity intolerance, the results of autonomic testing were heterogenous, with orthostatic hypotension in 1 patient, excessive postural tachycardia typical of postural tachycardia syndrome in 4 patients, and postural hypertension in 3 patients.

Citing Articles

Case report: Treatable immune-mediated severe orthostatic hypotension in SARS-CoV-2 infection.

Theiler K, Bronchain M, Grouzmann E, Duflon S, Hirt L, Du Pasquier R Front Neurosci. 2025; 18():1505727.

PMID: 39840012 PMC: 11746903. DOI: 10.3389/fnins.2024.1505727.


Unraveling the relevance of SARS-Cov-2 infection and ferroptosis within the heart of COVID-19 patients.

Alizadeh Saghati A, Sharifi Z, Hatamikhah M, Salimi M, Talkhabi M Heliyon. 2024; 10(17):e36567.

PMID: 39263089 PMC: 11388749. DOI: 10.1016/j.heliyon.2024.e36567.


Composite Autonomic Symptom Score-31 for the diagnosis of cardiovascular autonomic dysfunction in long-term coronavirus disease 2019.

Yar T, Salem A, Rafique N, Latif R, Siddiqui I, Shaikh M J Family Community Med. 2024; 31(3):214-221.

PMID: 39176014 PMC: 11338387. DOI: 10.4103/jfcm.jfcm_20_24.


Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia.

Naik H, Cooke E, Boulter T, Dyer R, Bone J, Tsai M BMJ Open. 2024; 14(5):e085272.

PMID: 38740499 PMC: 11097836. DOI: 10.1136/bmjopen-2024-085272.


Value of I-MIBG SPECT for the assessment of dysautonomia in patients with long COVID.

Xavier de Brito A, Bronchtein A, Schaustz E, Glavam A, Pinheiro M, Secco J Int J Cardiol Heart Vasc. 2024; 52:101413.

PMID: 38694270 PMC: 11060949. DOI: 10.1016/j.ijcha.2024.101413.


References
1.
Low P, Tomalia V, Park K . Autonomic function tests: some clinical applications. J Clin Neurol. 2013; 9(1):1-8. PMC: 3543903. DOI: 10.3988/jcn.2013.9.1.1. View

2.
Kanjwal K, Karabin B, Kanjwal Y, Grubb B . Postural orthostatic tachycardia syndrome following Lyme disease. Cardiol J. 2011; 18(1):63-6. View

3.
Ghosh R, Roy D, Sengupta S, Benito-Leon J . Autonomic dysfunction heralding acute motor axonal neuropathy in COVID-19. J Neurovirol. 2020; 26(6):964-966. PMC: 7485423. DOI: 10.1007/s13365-020-00908-2. View

4.
PALMERO H, Caeiro T, Josa D . Distinctive abnormal responses to tilting test in chronic Chagas' disease. Klin Wochenschr. 1980; 58(23):1307-11. DOI: 10.1007/BF01478139. View

5.
Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni M . Guillain-Barré Syndrome Associated with SARS-CoV-2. N Engl J Med. 2020; 382(26):2574-2576. PMC: 7182017. DOI: 10.1056/NEJMc2009191. View